Cost-effectiveness of Tenecteplase Versus Alteplase for Acute Ischemic Stroke in Canada Based on the AcT Trial.
- DOI
- 10.1017/cjn.2026.10669
- Published
- 2026 Sep 25
- Container
- The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1017/cjn.2026.10669,
title = {Cost-effectiveness of Tenecteplase Versus Alteplase for Acute Ischemic Stroke in Canada Based on the AcT Trial.},
author = {Aubin MC and Becker DL and Cartier S and Zheng JJ and Notte C and Blacquiere D and Menon BK},
year = {2026},
journal = {The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques},
doi = {10.1017/cjn.2026.10669},
url = {https://doi.org/10.1017/cjn.2026.10669}
}RIS
TY - JOUR TI - Cost-effectiveness of Tenecteplase Versus Alteplase for Acute Ischemic Stroke in Canada Based on the AcT Trial. AU - Aubin MC AU - Becker DL AU - Cartier S AU - Zheng JJ AU - Notte C AU - Blacquiere D AU - Menon BK PY - 2026 JO - The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques DO - 10.1017/cjn.2026.10669 UR - https://doi.org/10.1017/cjn.2026.10669 ER -
APA
MC, A., DL, B., S, C., JJ, Z., C, N., D, B., & BK, M. (2026). Cost-effectiveness of Tenecteplase Versus Alteplase for Acute Ischemic Stroke in Canada Based on the AcT Trial.. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. https://doi.org/10.1017/cjn.2026.10669
Source records
- pubmed · retrieved 2026-09-25T20:55:17.428Z